Hematologia

Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F

Źródło‎: Blood Adv. 2022;6(3):785-92.

Indeks‎: PubMed 34781363

DOI‎: 10.1182/bloodadvances.2021005627

https://pubmed.ncbi.nlm.nih.gov/34781363/ (opens new window)

Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. (opens new window)

Leahy MF, Trentino KM, May C, Swain SG, Chuah H, Farmer SL.

Źródło‎: Transfusion 2017;57(9):2189-96.

Indeks‎: PubMed 28671296

DOI‎: 10.1111/trf.14191

https://www.ncbi.nlm.nih.gov/pubmed/28671296 (opens new window)

Impact of a conservative red blood cell transfusion strategy in children undergoing hematopoietic stem cell transplantation. (opens new window)

Lightdale JR, Randolph AG, Tran CM, Jiang H, Colon A, Houlahan K, Billet A, Sloan S, Lehmann LE.

Źródło‎: Biol Blood Marrow Transplant 2012;18(5):813-7.

Indeks‎: PubMed 22080050

DOI‎: 10.1016/j.bbmt.2011.10.043

https://www.ncbi.nlm.nih.gov/pubmed/22080050 (opens new window)

The cost of blood: a study of the total cost of red blood cell transfusion in patients with β-thalassemia using time-driven activity-based costing. (opens new window)

McQuilten ZK, Higgins AM, Burns K, Chunilal S, Dunstan T, Haysom HE, Kaplan Z, Rushford K, Saxby K, Tahiri R, Waters N, Wood EM.

Źródło‎: Transfusion 2019;59(11):3386-95.

Indeks‎: PubMed 31664712

DOI‎: 10.1111/trf.15558

https://www.ncbi.nlm.nih.gov/pubmed/31664712 (opens new window)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (opens new window)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

Źródło‎: Transfusion 2015;55(12):2807-15.

Indeks‎: PubMed 26264557

DOI‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (opens new window)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (opens new window)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Źródło‎: Cancer 2013;119(1):107-14.

Indeks‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (opens new window)

Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece. (opens new window)

Nikolaidi E, Hatzikou M, Geitona M.

Źródło‎: Cost Eff Resour Alloc 2013;11(1):16.

Indeks‎: PubMed 23870502

DOI‎: 10.1186/1478-7547-11-16

https://www.ncbi.nlm.nih.gov/pubmed/23870502 (opens new window)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (opens new window)

Pashos CL, Larholt K, Fraser KA, McKenzie RS, Senbetta M, Piech CT.

Źródło‎: Support Care Cancer 2012;20(1):159-65.

Indeks‎: PubMed 21359879

DOI‎: 10.1007/s00520-010-1083-7

https://www.ncbi.nlm.nih.gov/pubmed/21359879 (opens new window)

Comparative net cost impact of the utilization of romiplostim and intravenous immunoglobulin for the treatment of patients with immune thrombocytopenia in Québec, Canada. (opens new window)

Pettigrew M, Garces K, Deuson R, Kassis J, Laroche V

Źródło‎: J Med Econ 2013;16(2):318-26.

Indeks‎: PubMed 23216012

DOI‎: 10.3111/13696998.2012.756400

https://www.ncbi.nlm.nih.gov/pubmed/23216012 (opens new window)

Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study. (opens new window)

Ravangard R, Mirzaei Z, Keshavarz K, Haghpanah S, Karimi M.

Źródło‎: Hematology 2018;23(7):417-22.

Indeks‎: PubMed 29157136

DOI‎: 10.1080/10245332.2017.1404262

https://www.ncbi.nlm.nih.gov/pubmed/29157136 (opens new window)

The burden of blood transfusion: a utilization and economic analysis--a pilot study in patients with chemotherapy-induced anemia (CIA). (opens new window)

Reitan JF, Kudrik FJ, Fox K, van Breda A, Shreay S, Corey-Lisle PK.

Źródło‎: J Med Econ 2013;16(5):633-8.

Indeks‎: PubMed 23425291

DOI‎: 10.3111/13696998.2013.778269

https://www.ncbi.nlm.nih.gov/pubmed/23425291 (opens new window)

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. (opens new window)

Sarode R, Refaai MA, Matevosyan K, Burner JD, Hampton S, Rutherford C.

Źródło‎: Transfusion 2010;50(2):487-92.

Indeks‎: PubMed 19804569

DOI‎: 10.1111/j.1537-2995.2009.02413.x

https://www.ncbi.nlm.nih.gov/pubmed/19804569 (opens new window)

Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. (opens new window)

Stallworth JR, Jerrell JM, Tripathi A.

Źródło‎: Am J Hematol 2010;85(10):795-7.

Indeks‎: PubMed 20645429

DOI‎: 10.1002/ajh.21772

https://www.ncbi.nlm.nih.gov/pubmed/20645429 (opens new window)

Increased hospital costs associated with red blood cell transfusion. (opens new window)

Trentino KM, Farmer SL, Swain SG, Burrows SA, Hofmann A, Ienco R, Pavey W, Daly FF, Van Niekerk A, Webb SA, Towler S, Leahy MF.

Źródło‎: Transfusion 2015;55(5):1082-9.

Indeks‎: PubMed 25488623

DOI‎: 10.1111/trf.12958

https://www.ncbi.nlm.nih.gov/pubmed/25488623 (opens new window)

OPŁACALNOŚĆ METOD ALTERNATYWNYCH WOBEC TRANSFUZJI

Hematologia

polski

Hematologia

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs. (opens new window)

Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe. (opens new window)

Restrictive blood transfusion practices are associated with improved patient outcomes. (opens new window)

Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom. (opens new window)

Recombinant activated factor VII use in critically ill infants with active hemorrhage. (opens new window)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (opens new window)

Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. (opens new window)

Impact of a conservative red blood cell transfusion strategy in children undergoing hematopoietic stem cell transplantation. (opens new window)

The cost of blood: a study of the total cost of red blood cell transfusion in patients with β-thalassemia using time-driven activity-based costing. (opens new window)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (opens new window)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (opens new window)

Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece. (opens new window)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (opens new window)

Comparative net cost impact of the utilization of romiplostim and intravenous immunoglobulin for the treatment of patients with immune thrombocytopenia in Québec, Canada. (opens new window)

Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study. (opens new window)

The burden of blood transfusion: a utilization and economic analysis--a pilot study in patients with chemotherapy-induced anemia (CIA). (opens new window)

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. (opens new window)

Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. (opens new window)

Increased hospital costs associated with red blood cell transfusion. (opens new window)

Komitet Łączności ze Szpitalami (KŁS)

Informacje medyczne — pakiety

Materiały wideo

Hematologia

Wybierz swój język

Udostępnij